IP Verse

Aqueous Suspensions Of Tmc278 - EP2040671

The patent EP2040671 was granted to Janssen R&D Ireland on Jan 24, 2018. The application was originally filed on Jun 22, 2007 under application number EP07786802A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2040671

JANSSEN R&D IRELAND
Application Number
EP07786802A
Filing Date
Jun 22, 2007
Status
Opposition Rejected
Aug 14, 2020
Grant Date
Jan 24, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFOct 23, 2018-ADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS6221400
INTERNATIONAL-SEARCH-REPORTWO03016306
INTERNATIONAL-SEARCH-REPORTWO2006106103
INTERNATIONAL-SEARCH-REPORTWO2007082922
OPPOSITIONWO03016306
OPPOSITIONWO2006106103
OPPOSITIONWO2007082922

Non-Patent Literature (NPL) Citations (3) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Merisko-Liversidge et al., "Nanosizing: a formulation approach for poorly-water-soluble compounds", European Journal of Pharmaceutical Sciences, (20080000), vol. 18, no. 2, pages 113 - 120, XP055101534
OPPOSITION- JANSSEN et al., "In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6- dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)", J. Med. Chem., (20050000), vol. 48, no. 6, pages 1901 - 1909, XP002460263
OPPOSITION- RABINOW, "Nanosuspensions in drug delivery", Nat Rev., (20040900), vol. 3, pages 785 - 796, XP002406985

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents